The coronaviral vaccine, which is due to be available for sale in 2020, has been hailed as a major step forward in tackling the disease.
But the Royal College of Physicians has warned that the vaccine’s effectiveness and safety has been questioned, and the government has pledged to increase funding to improve the vaccine.
The vaccine, developed by AstraZeneca, was approved by the European Union in June.
But in a letter to Health Secretary Nick Gibb, the RCP warned the vaccine had been criticised by some medical experts and its effectiveness had been questioned by the independent Vaccine Advisory Committee.
“The Government has indicated it is keen to increase the funding for the UK to enable the development of the UK’s first vaccine for the coronasophage, which would provide a substantial boost to the UK economy and contribute significantly to reducing the spread of the disease,” the letter reads.
The RCP said it was worried about the impact of the coronavalvirus vaccine on children and families.””
The Royal College recommends that the Government increase funding for this important initiative.”
The RCP said it was worried about the impact of the coronavalvirus vaccine on children and families.
“While the vaccine is an important step forward, it is not without risk,” it said.
“The safety of the vaccine has been raised and it needs to be assessed and the full impact of its implementation assessed as a whole.”
The UK government is also investigating how to ensure a UK vaccine does not fall foul of European standards.
Last week, the UK Government announced that it was considering a possible exemption for children aged under 14 from the requirements of the European Medicines Agency (EMA) for the delivery of a coronavaccine in 2020.
The exemption could be based on a specific recommendation from the EMA’s Medicines and Healthcare Products Regulatory Agency (MHRA).
It comes after the MHRA announced that the country would now be able to import the coronava vaccine if it was deemed necessary.
“It is important that all people are protected from coronaviruses, and we will continue to work closely with the European Commission to ensure that all medicines and vaccines are safe and effective,” a Health Ministry spokesperson said.